AdvisorShares Psychedelics ETF
Compare this stock
PSIL Stock Report Card
$
13%
Performance
Score:
10/100
PSIL returned -44.39% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.
Technicals
Score:
11/100
PSIL receives a 10 of 100 based on 14 indicators. 1 are bullish, 12 are bearish.
Volatility
Score:
21/100
PSIL has had a lower than average amount of volatility over the last 12 months giving it a score of 21 of 100.
AdvisorShares Psychedelics ETF Summary
Financial Services
Asset Management
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Checkout Similar Companies
PSIL scored poorly on our reportcard. Here are some similar companies and how they performed.
